MedPath

Carbon Dioxide Acupulse Laser Treatment Versus Sham Treatment and Sexual Dysfunction.

Not Applicable
Conditions
Sexual Dysfunction
Interventions
Device: Carbon dioxide laser
Device: Sham laser treatment
Registration Number
NCT05097469
Lead Sponsor
Rambam Health Care Campus
Brief Summary

The study is intended to assess the safety and efficacy of Carbon dioxide AcuPulse laser treatment in patients with sexual dysfunction. Eligible subjects will be randomized to either receive 3 laser or 3 sham treatment sessions, 4 weeks apart and 3 follow up visits 3, 6 and 12 months following the last treatment.

Detailed Description

Following a screening visit, eligible subjects will be enrolled into the study. Subjects will be randomized into either laser treatment or sham treatment. Each subject will receive 3 treatments 4 weeks apart and 3 follow up visits, at 3, 6 and 12 months following the last treatment.

Further demographic information and patient history will be obtained from the subjects' electronic files.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • Negative urine analysis.
  • Normal Pap smear test from the recent 3 years.
  • No previous gynecological laser treatments.
  • Able and willing to comply with the treatment/follow-up schedule and requirements.
Exclusion Criteria
  • Active genital infection.
  • Subject presenting abnormal Pap result from the last three years.
  • Recurring urinary tract infection or recurring infection of genital herpes or candida (> 2 episodes in the recent year).
  • Transvaginal mesh implant.
  • Serious systemic disease or any chronic condition that could interfere with study compliance.
  • Any vaginal bleeding of unknown reason.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Laser treatmentCarbon dioxide laserCarbon dioxide laser treatment
Sham treatmentSham laser treatmentSham laser treatment
Primary Outcome Measures
NameTimeMethod
Vaginal health indexFrom treatment up to 12 months post treatment

Change in total and specific vaginal health index scores

Secondary Outcome Measures
NameTimeMethod
Sexual intercourseFrom treatment up to 12 months post treatment

Change in monthly sexual intercourse rate

Female sexual function indexFrom treatment up to 12 months post treatment

Change in total and specific female sexual function index questionnaire scores

Trial Locations

Locations (1)

Rambam health care campus

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath